DeepMed Research

SORIN GROUP ITALIA SRL

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.

Terminated

Conditions: Epilepsy

First Posted Date: 2023-08-04

Last Posted Date: 2024-12-03

Lead Sponsor: LivaNova

Target Recruit Count: 15

Registration Number: NCT05975931

Locations: 🇬🇧
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation

Not Applicable

Active, not recruiting

Conditions: OSA
Apnea, Obstructive
Apnea
Hypopnea, Sleep
Obstructive Sleep Apnea
Apnea, Obstructive Sleep
Apnea+Hypopnea

Interventions: Device: Hypoglossal Nerve Stimulation

First Posted Date: 2021-07-06

Last Posted Date: 2025-05-01

Lead Sponsor: LivaNova

Target Recruit Count: 150

Registration Number: NCT04950894

Locations: 🇺🇸
Sacramento Ent, Roseville, California, United States
🇺🇸
Advanced Ent Associates, Atlanta, Georgia, United States
🇺🇸
Morton Plant Mease Health Care, Safety Harbor, Florida, United States

and more 17 locations

Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associated With VNS Therapy in UK.

Active, not recruiting

Conditions: Epilepsy

First Posted Date: 2021-03-03

Last Posted Date: 2025-03-07

Lead Sponsor: LivaNova

Target Recruit Count: 97

Registration Number: NCT04779814

Locations: 🇬🇧
Bristol Royal Hospital For Children, Bristol, United Kingdom
🇬🇧
Nottingham Children's Hospital, Nottingham, United Kingdom
🇬🇧
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

and more 2 locations

The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Terminated

Conditions: Treatment Resistant Depression

First Posted Date: 2021-02-15

Last Posted Date: 2024-12-20

Lead Sponsor: LivaNova

Target Recruit Count: 138

Registration Number: NCT04753385

Locations: 🇺🇸
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States
🇺🇸
UT Center of Excellence on Mood Disorders, Houston, Texas, United States

and more 30 locations

XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)

Withdrawn

Conditions: Epilepsy, Tonic-Clonic

First Posted Date: 2020-02-25

Last Posted Date: 2020-08-25

Lead Sponsor: LivaNova

Registration Number: NCT04282681

Locations: 🇧🇪
Universitair Ziekenhuis Gent, Ghent, Belgium

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Not Applicable

Recruiting

Conditions: Treatment Resistant Depression

Interventions: Device: Vagus Nerve Stimulation (VNS)

First Posted Date: 2019-03-25

Last Posted Date: 2024-12-10

Lead Sponsor: LivaNova

Target Recruit Count: 6800

Registration Number: NCT03887715

Locations: 🇺🇸
Millenia Psychiatry & Research, Inc, Orlando, Florida, United States
🇺🇸
Quantum Laboratories Inc., Pompano Beach, Florida, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

and more 93 locations

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

Completed

Conditions: Seizures
Drug Resistant Epilepsy
Epilepsy

Interventions: Device: Vagus Nerve Stimulation (VNS) Therapy

First Posted Date: 2018-05-18

Last Posted Date: 2024-11-22

Lead Sponsor: LivaNova

Target Recruit Count: 827

Registration Number: NCT03529045

Locations: 🇮🇳
Deenanath Mangeshkar Hospital and Research Centre, Pune, Maharashtra, India
🇨🇳
Guangzhou Women and Children's Medical Center, Guangzhou, China
🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States

and more 58 locations

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Not Applicable

Completed

Conditions: Epilepsy, Tonic-Clonic
Epilepsies, Partial

Interventions: Device: Microburst Stimulation

First Posted Date: 2018-02-27

Last Posted Date: 2022-10-25

Lead Sponsor: LivaNova

Target Recruit Count: 33

Registration Number: NCT03446664

Locations: 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
🇺🇸
Weil-Cornell Medical College, Ithaca, New York, United States
🇺🇸
Rush University, Chicago, Illinois, United States

and more 6 locations

ANTHEM-HFrEF Pivotal Study

Not Applicable

Terminated

Conditions: Heart Failure
Heart Failure, Congestive
Heart Failure, Systolic

Interventions: Device: VITARIA System

First Posted Date: 2018-02-07

Last Posted Date: 2023-10-10

Lead Sponsor: LivaNova

Target Recruit Count: 533

Registration Number: NCT03425422

Locations: 🇺🇸
Mount Sinai School St. Luke's, New York, New York, United States
🇺🇸
UnityPoint Health - Methodist Hospital, Peoria, Illinois, United States
🇺🇸
Long Beach Memorial Hospital, Long Beach, California, United States

and more 19 locations

A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.

Recruiting

Conditions: Treatment Resistant Depression

Interventions: Device: Vagal Nerve Simulation (VNS) Therapy

First Posted Date: 2017-10-25

Last Posted Date: 2025-04-08

Lead Sponsor: LivaNova

Target Recruit Count: 500

Registration Number: NCT03320304

Locations: 🇩🇪
Universitätsklinikum Bonn, Bonn, Germany
🇩🇪
LVR-Hospital Essen, Essen, Germany
🇩🇪
Universitätsklinikum Frankfurt, Frankfurt, Germany

and more 15 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy